Table 2.
Demographic data for all patients.
| SX18 | FX15 | Inspire6F | p Value | |
|---|---|---|---|---|
| Number | 20 | 20 | 20 | — |
| Gender (% male) | 65.0 | 55.0 | 60.0 | .812 |
| Age (years) | 65.3 ± 13.1 | 69.4 ± 11.3 | 70.7 ± 12.7 | .364 |
| Weight (kg) | 84.9 ± 19.9 | 89.4 ± 28.3 | 88.0 ± 15.0 | .798 |
| Height (cm) | 169.7 ± 10.7 | 169.2 ± 10.3 | 169.1 ± 13.3 | .985 |
| BSA | 1.9 ± .3 | 2.0 ± .3 | 2.0 ± .2 | .717 |
| Operative procedures | CABG (9) | CABG (8) | CABG (7) | |
| CABG/valve (6) | CABG/valve (4) | CABG/valve (7) | ||
| Isolated valve (5) | Isolated valve (8) | Isolated valve (7) | ||
| Preoperative EF (%) | 49.3 ± 14.5 | 49.8 ± 13.5 | 53.0 ± 9.8 | .604 |
| Mortality risk* | — | .023 ± .028 | .026 ± .021 | .606 |
| Morbidity risk* | — | .159 ± .104 | .178 ± 0.094 | .540 |
| Risk for long length of stay* | — | .669 ± .057 | .079 ± .054 | .495 |
| Permanent stroke risk* | — | .016 ± .016 | .017 ± .011 | .726 |
| Prolonged ventilation risk* | — | .099 ± .080 | .104 ± .059 | .775 |
| Renal failure risk* | — | .046 ± .052 | .057 ± .047 | .466 |
| Reoperation risk* | — | .063 ± .029 | .071 ± .030 | .405 |
CABG, coronary artery bypass graft surgery; EF, ejection fraction. All data are mean ± SD.
*
Comparison only made between FX15 and Inspire groups using STS risk stratification calculator, which was not available in SX18 group.